Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Medicare Monday: Part D premiums expected to drop in 2018

August 7, 2017

CMS announced Medicare Part D prescription drug plan premiums are projected to drop.

Read More

ICYMI: New report outlines steps for greater transparency in health care

August 4, 2017

A new report outlines steps for greater transparency in health care.

Read More

PhRMA Statement on Senate Passage of PDUFA VI Reauthorization

August 3, 2017

PhRMA applauds the Senate for passage of the Prescription Drug, Biosimilar and Generic Drug User Fee Acts.

Read More

PhRMA Supports President’s Commission’s Holistic Approach on Opioid Crisis

August 2, 2017

President’s Commission on Combatting Drug Addiction and the Opioid Crisis report reflects an approach that America’s biopharmaceutical companies support.

Read More

Medicare Monday: Medicare turns 52!

July 31, 2017

This weekend (July 30) marked 52 years since Medicare was signed into law.

Read More

Video: PhRMA CEO discusses medicine costs with CNBC's Squawk Box

July 31, 2017

PhRMA president and CEO Stephen J. Ubl joined Squawk Box to put medicine costs in context and solutions to continue U.S. leadership in medical innovation.

Read More

Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation

July 31, 2017

Innovation and discovery happening within the Bay Area is transforming biopharmaceuticals.

Read More

Biopharmaceutical industry policies aim to increase access to clinical trial data

July 27, 2017

The biopharmaceutical industry has been at the forefront of initiatives to improve access to clinical trial data.

Read More

Opportunities to build upon enhanced competition for medicines in the marketplace

July 27, 2017

Hatch-Waxman is expected to continue to spur robust brand and generic competition in the years to come.

Read More

Finding cures for incurable diseases

July 25, 2017

74 percent of the medicines in the pipeline have the potential to be first-in-class therapies.

Read More